VisionEvery audit we manage, every compliance strategy we design, and every submission we guide is driven by one purpose: To help breakthrough technologies reach patients faster - safely, ethically, and globally.
MissionWe take the burden of compliance off your shoulders – transforming red tape into a roadmap. From product design to post-market surveillance, our experts integrate regulatory strategy into your business model, giving you the freedom to focus on what you do best: changing lives through innovation.
CORE VALUES
Unmatched knowledge. Uncompromising ethics. Our team combines decades of regulatory experience with a deep understanding of MedTech and Biotech innovation. We lead with transparency, honesty, and precision – guiding you through every requirement with confidence and clarity.
The world moves fast – so do we. Regulations evolve, markets expand, and technology disrupts everything. We thrive in that change. Our approach blends regulatory mastery with creative problem-solving, helping you stay compliant and competitive.
Your vision becomes our mission. We embed ourselves in your team, listen deeply, and tailor every strategy to your unique goals. Our success is measured by your market approval, your investor confidence, and your growth.
Worldwide reach with on-the-ground understanding. From Europe to Asia to the Americas, our experts combine global regulatory expertise with local intelligence. We know the nuances that make or break submissions – and we use that insight to smooth your path to market everywhere you operate. “Global confidence starts with local precision – and we bring both.”
Srinivasan is a dynamic quality assurance professional with extensive experience in NABL/ISO consulting, clinical research, and regulatory compliance. Skilled in QMS implementation, risk assessment, and audits, he has deep expertise across standards including ISO 9001, ISO 13485, ISO 15189, ISO 27001, and ICH-GCP. His strength lies in building robust quality systems that ensure regulatory readiness and operational excellence.
Rahul brings a strong blend of technical expertise and healthcare innovation to D2R Global Consulting. A dual-degree graduate in Computer Science and Engineering from the University of Calcutta, he specializes in building scalable digital health systems and global compliance frameworks. His work at Tricog Health and NexaNeura Technologies reflects a passion for leveraging technology to enhance patient outcomes and healthcare delivery worldwide.
Dr. Deepika is a seasoned biotech professional with extensive experience translating healthcare innovations into market-ready solutions. Her expertise spans strategic planning and product lifecycle management within medtech and healthtech domains. Experienced in bridging regulatory frameworks and business objectives, she enables organisations to navigate complex compliance landscapes and bring impactful technologies to patients.
A scientist by training and strategist by intent, Dr. Swapnil leads the Biomedical vertical at D2R Global Consulting. He brings a decade of experience across science, entrepreneurship, and policy, and heads IIT Guwahati BioNEST, a leading biotech innovation hub. His work has supported over eighty startups and enabled more than twenty five crore in funding to drive impactful healthcare innovation in India.
Dr. Parthiban brings over 15 years of experience in AI-driven research, drug discovery, and computational sciences. A PhD graduate from the Indian Institute of Science, he has held leadership roles at AstraZeneca, Jubilant Biosys, GVK BIO, and Parthys Reverse Informatics. His expertise spans machine learning, cheminformatics, and data-driven innovation for healthcare and life sciences.
Dr. Kannan brings over 25 years of global experience in oncology and clinical development. He has led pivotal solid tumor programs during his tenure at Takeda Oncology and Aveo Oncology, shaping multiple international clinical trials. Currently serving as Chief Development Officer at Wells Therapeutics Inc., he drives strategy, development, and fundraising for its emerging oncology pipeline.
Srinivasan is a dynamic quality assurance professional with extensive experience in NABL/ISO consulting, clinical research, and regulatory compliance. Skilled in QMS implementation, risk assessment, and audits, he has deep expertise across standards including ISO 9001, ISO 13485, ISO 15189, ISO 27001, and ICH-GCP. His strength lies in building robust quality systems that ensure regulatory readiness and operational excellence.
Rahul brings a strong blend of technical expertise and healthcare innovation to D2R Global Consulting. A dual-degree graduate in Computer Science and Engineering from the University of Calcutta, he specializes in building scalable digital health systems and global compliance frameworks. His work at Tricog Health and NexaNeura Technologies reflects a passion for leveraging technology to enhance patient outcomes and healthcare delivery worldwide.
Dr. Deepika is a seasoned biotech professional with extensive experience translating healthcare innovations into market-ready solutions. Her expertise spans strategic planning and product lifecycle management within medtech and healthtech domains. With a strong track record of bridging regulatory frameworks and business objectives, she enables organisations to navigate complex compliance landscapes and bring impactful technologies to patients.
A scientist by training and strategist by purpose, Dr. Swapnil leads the Biomedical vertical at D2R Global Consulting. He brings a decade of experience bridging science, entrepreneurship, and policy, and currently heads IIT Guwahati BioNEST (TIDF), one of India’s most vibrant biotech innovation hubs. His leadership has enabled 80+ startups and mobilized over ₹25 crore in innovation funding, driving deep science toward real-world healthcare impact.
Dr. Parthiban brings over 15 years of experience in AI-driven research, drug discovery, and computational sciences. A PhD graduate from the Indian Institute of Science, he has held leadership roles at AstraZeneca, Jubilant Biosys, GVK BIO, and Parthys Reverse Informatics. His expertise spans machine learning, cheminformatics, and data-driven innovation for healthcare and life sciences.
Dr. Kannan brings over 25 years of global experience in oncology and clinical development. He has led pivotal solid tumor programs during his tenure at Takeda Oncology and Aveo Oncology, shaping multiple international clinical trials. Currently serving as Chief Development Officer at Wells Therapeutics Inc., he drives strategy, development, and fundraising for its emerging oncology pipeline.